Table 3.
STEP I | STEP II | STEP III | STEP IV | STEP V | STEP VI | |
---|---|---|---|---|---|---|
Nociceptive pain | ||||||
SIGN [12] |
Paracetamol or NSAIDs | Weak opioids or topical NSAIDs | Strong opioids | |||
CDW [49] | NSAIDs or COX-2 inhibitors | |||||
AGS [91] | Paracetamol (up to 4 g/day) | NSAIDs | Opioids | |||
DHHS [92] |
Ia: paracetamol Ib: ibuprofen or naproxen Ic: paracetamol plus ibuprofen or naproxen |
IIa: codeine IIb: tramadol | IIIa: low-dose morphine or buprenorphine patch (if morphine is ineffective) IIIb: high-dose morphine or 5–30 mg of oxycodone twice a day or fentanyl/buprenorphine patch if morphine is ineffective IIIc: 50 mg of tapentadol twice daily |
|||
ESCEO [93] | Chondroitin sulfate or glucosamine sulfate | Paracetamol or topical NSAIDs | NSAIDs | Intra-articular injection of hyaluronic acid or corticosteroids | Duloxetine | Surgery |
Neuropathic pain | ||||||
SIGN [12] | Amitriptyline or gabapentin | Pregabalin | SNRIs | 5% lidocaine | Opioids | 9% capsaicin |
CDW [49] | Tricyclic antidepressants | Gabapentin/pregabalin or SNRIs (duloxetine) | Other anticonvulsants | Low-dose opioids | ||
AGS [91] | Duloxetine or pregabalin | |||||
DHHS [92] | Amitriptyline/imipramine | Gabapentin (1st line) or pregabalin (2nd line) or 0.075% capsaicin cream | Duloxetine or lidocaine plasters (5%-700 mg/plaster) or capsaicin patch (8%-179 mg/plaster) |
|||
Practice [94] | Duloxetine or TCA | Lidocaine or ketamine | ||||
NICE [2]. | Antidepressants | Gabapentin or pregabalin | ||||
NeuPSIG [14] | TCA, SNRI, or gabapentin/pregabalin | Tramadol, lidocaine, and capsaicin patches | Opioids or botulin toxin-A |